POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER

Clinical safety rating: caution

Comprehensive clinical and safety monograph for POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER).

How it works

Potassium chloride provides potassium ions for maintenance of normal electrolyte balance; potassium is the principal intracellular cation. Dextrose provides caloric supplementation. Lactated Ringer's solution provides electrolytes (sodium, chloride, potassium, calcium, lactate) to maintain fluid and electrolyte balance, with lactate serving as a bicarbonate precursor.

What the body does with it

Metabolism	Potassium: primarily cellular uptake via Na+/K+-ATPase, excreted renally. Dextrose is rapidly metabolized via glycolysis to carbon dioxide and water, yielding energy; excess may be stored as glycogen or fat. Lactate is converted to bicarbonate in the liver via gluconeogenesis.
Excretion	Renal excretion of potassium: >90% eliminated by kidneys, with obligatory secretion in distal tubules and collecting ducts. Fecal excretion: <10% via colonic secretion. Minimal biliary elimination.
Half-life	Potassium has no true elimination half-life as it is not metabolized; distribution half-life is approximately 2 hours for intravenous potassium. Clinically, redistribution from extracellular to intracellular space (driven by insulin, beta-adrenergic tone, and acid-base status) determines serum concentration changes.
Protein binding	<2% bound to plasma proteins; potassium is primarily free and ionized in serum.
Volume of Distribution	0.5-0.7 L/kg (total body water), reflecting distribution primarily in extracellular fluid and rapid equilibration with intracellular compartment. Clinical meaning: Large Vd indicates extensive tissue uptake; loading doses may be required for repletion.
Bioavailability	Intravenous: 100% (administered directly into bloodstream). Oral: ~90% absorbed; first-pass effect negligible. Not administered via other routes.
Onset of Action	Intravenous: Onset of effect on serum potassium levels within minutes; correction of hypokalemia typically observed within 1-2 hours. Redistribution to intracellular space occurs rapidly.
Duration of Action	Intravenous: Duration of effect on serum potassium depends on dose and continuous infusion; for a single dose, effect may last 2-4 hours due to rapid redistribution and renal excretion. Continuous infusion is needed to maintain serum levels.

Classification & Brands

Dosing & administration

Intravenous administration of 5 mEq potassium chloride in 5% dextrose and lactated Ringer's solution per 100 mL bag, administered at a rate not exceeding 10 mEq/hour (0.3 mEq/kg/hour) for adults, with typical daily dose of 40-100 mEq depending on serum potassium levels and clinical status; continuous infusion or intermittent dosing as per protocol.

Dosage form	INJECTABLE
Renal impairment	GFR > 50 mL/min: no adjustment. GFR 30-50 mL/min: reduce dose by 25-50% and monitor potassium. GFR 10-29 mL/min: administer with extreme caution; initial dose 50% of usual and titrate based on serum K+. GFR < 10 mL/min: avoid unless severe hypokalemia with dialysis; use with close monitoring.
Liver impairment	Child-Pugh A: no adjustment. Child-Pugh B: reduce initial dose by 25% and monitor potassium. Child-Pugh C: use with caution; reduce dose by 50% and frequent monitoring due to increased risk of hyperkalemia from altered electrolyte handling.
Pediatric use	Intravenous: 0.5-1 mEq/kg/dose (maximum 30 mEq/dose) administered at a rate not exceeding 0.3 mEq/kg/hour; daily requirement 2-3 mEq/kg/day. Specific concentration in dextrose 5% and lactated Ringer's solution should be verified for pediatric use; typically not recommended as standard solution due to dextrose content.
Geriatric use

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

Breastfeeding	Compatible with breastfeeding. Potassium is a normal milk constituent; M/P ratio not established. Dextrose and lactated Ringer's are safe. No adverse effects reported.
Teratogenic Risk	Potassium chloride is not teratogenic. Dextrose and lactated Ringer's are generally safe. No increased risk of fetal malformations across trimesters. High doses or rapid infusion may cause maternal electrolyte disturbances affecting fetal well-being.

Warnings & precautions

■ FDA Black Box Warning

Potassium chloride injection concentrate must be diluted before use. Do not administer undiluted or rapid infusion; can cause cardiac arrest or fatal hyperkalemia.

Side Effect Profile

Serious Effects

Absolute Contraindications

["Hyperkalemia (serum potassium >5.5 mEq/L)","Severe renal impairment with oliguria or anuria","Hypersensitivity to any component","In patients with conditions predisposing to hyperkalemia (e.g., Addison's disease, severe burns, crush injuries)","Lactated Ringer's contraindicated in metabolic alkalosis or severe lactic acidosis"]

Clinical Precautions

Precautions

["Risk of hyperkalemia, especially in renal impairment or patients on ACE inhibitors/ARBs/potassium-sparing diuretics","Monitor serum potassium and ECG during infusion","Avoid extravasation due to risk of tissue necrosis","Use caution in patients with heart failure, pulmonary edema, or renal impairment","Dextrose solutions may cause hyperglycemia in diabetic patients"]

Clinical Tips & Counseling

Drug interactions

Loading safety data…